ClinicalTrials.Veeva
Menu

Find clinical trials for Glioblastoma (GBM) in Boston, MA

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Glioblastoma
Recurrence
Glioma
Brain Cancer
Astrocytoma
Cancer
Gliosarcoma

Glioblastoma (GBM) trials near Boston, MA, USA:

INO-5401 and INO-9012 Delivered by Electroporation (EP) in Combination With Cemiplimab (REGN2810) in Newly-Diagnosed Glioblastoma (GBM)

efficacy of INO-5401 and INO-9012 in combination with cemiplimab (REGN2810), with radiation and chemotherapy, in subjects with newly-diagnosed glioblastoma...

Active, not recruiting
Glioblastoma
Drug: Temozolomide
Biological: INO-9012

Phase 1, Phase 2

Inovio Pharmaceuticals
Inovio Pharmaceuticals

Boston, Massachusetts, United States and 20 other locations

trial will evaluate the safety, tolerability, immunogenicity, and preliminary efficacy of 8 mg ITI-1001 in participants with newly diagnosed glioblastoma...

Active, not recruiting
Glioblastoma
Drug: ITI-1001

Phase 1

Immunomic Therapeutics

Boston, Massachusetts, United States

A Phase 1b/2, Multicenter, Open-Label Study of ACP-196 in Subjects with Recurrent Glioblastoma Multiforme (GBM)...

Active, not recruiting
Glioblastoma Multiforme
Drug: ACP-196

Phase 1, Phase 2

Acerta Pharma
Acerta Pharma

Boston, Massachusetts, United States and 6 other locations

Part 1 is an open-label, single-arm, dose escalation study of MN-166 (ibudilast) and temozolomide (TMZ) combination treatment. Evaluate safety and to...

Active, not recruiting
Glioblastoma
Recurrent Glioblastoma
Drug: MN-166
Drug: Temozolomide

Phase 1, Phase 2

MediciNova

Boston, Massachusetts, United States

Glioblastoma (GBM) adaptive, global, innovative learning environment (GBM AGILE) is an international, seamless Phase II/II....

Enrolling
Glioblastoma
Drug: Temozolomide
Radiation: Radiation

Phase 2, Phase 3

Global Coalition for Adaptive Research

Boston, Massachusetts, United States and 61 other locations

with ipilimumab and surgery when used in the treatment of recurrent glioblastoma.The names of the study drugs involved in this study are:* N...

Active, not recruiting
Glioblastoma
Glioblastoma Multiforme
Drug: Ipilimumab-Placebo
Drug: Nivolumab-Placebo

Phase 1

Patrick Wen, MD

Boston, Massachusetts, United States and 3 other locations

This research study is studying troriluzole as a possible treatment for recurrent glioblastoma.The name of the study drug involved in this r...

Begins enrollment in 2 months
Glioblastoma
Recurrent Glioblastoma
Drug: Troriluzole

Early Phase 1

Eudocia Quant Lee, MD

Boston, Massachusetts, United States and 2 other locations

as a monotherapy in participants with newly diagnosed or recurrent epidermal growth factor receptor variant III (EGFRvIII)-positive glioblastoma...

Active, not recruiting
Glioblastoma
Drug: RO7428731

Phase 1

Roche
Roche

Boston, Massachusetts, United States and 10 other locations

OKN-007 combined with temozolomide(TMZ) in patients with recurrent glioblastoma(GBM). All patients will have been previously treate...

Active, not recruiting
Brain Glioblastoma
Recurrent Malignant Glioma
Drug: Temozolomide (TMZ)
Drug: OKN-007

Phase 2

Oblato

Providence, Rhode Island, United States and 12 other locations

This research study is studying a targeted therapy as a possible treatment for recurrent glioblastoma (GBM).The following intervent...

Active, not recruiting
Glioblastoma
Procedure: Surgery
Drug: Abemaciclib

Phase 2

Dana-Farber Cancer Institute
Dana-Farber Cancer Institute

Boston, Massachusetts, United States and 6 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems